Back to Search Start Over

An engineered β-galactosidase with improved stability and cross-correction for the potential treatment of GM1 Gangliosidosis via AAV gene therapy

Details

ISSN :
10967192
Volume :
138
Database :
OpenAIRE
Journal :
Molecular Genetics and Metabolism
Accession number :
edsair.doi...........f1c904fd0acaab184cf602a224ece715